Potential serum biomarkers for the prediction of the efficacy of escitalopram for treating depression.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of affective disorders"
DOI: 10.1016/j.jad.2019.03.008
Abstract: BACKGROUND Although several pharmacological treatment options for depression are currently available, a large proportion of patients still do not achieve a complete remission or respond adequately to the initial antidepressant prescribed for reasons that remain… read more here.
Keywords: depression; serum biomarkers; group; serum ... See more keywords